CD40LG and breast carcinoma: The IgM antitumor responses, both innate and adaptive, have not been studied as a function of time in breast cancer, and therefore we show a new approach for analyzing the mouse humoral immune response, and compare the evolution of IgG and IgM responses against the antigens of 4 T1 cells.